Then, we established a PC3 tumor model in nonobese diabetes/severe combined immune deficiency (NOD/SCID) mice, and in these tumor-carrying mice, EVs-TT #3 obviously decreased the binding of αPD-L1 and tumor PD-L1 (Fig. 6c). This evidence concerns the gene CD274 and neoplasm.